Endothelium-derived relaxing factor [EDRF, nitric oxide (NO) or a NO-containing compound] influ ences basal tone of cerebral blood vessels and mediates vasodilation in response to several stimuli. It is not known whether EDRF also modulates responses to cere bral vasoconstrictor stimuli in vivo. Our goal was to de termine whether formation of EDRF inhibits constrictor responses of large cerebral arteries to serotonin. We mea sured cerebral blood flow (micro spheres) and pial micro vascular pressure (servo null) in anesthetized rabbits and calculated resistance of large cerebral arteries. Responses to an inhibitor of NO formation, �-nitro-L-arginine (L NNA,3 mg/kg i.v.), were examined. L-NNA produced an increase in resistance of large arteries and total cerebral vascular resistance of approximately 15% (p < 0.05 for both variables) and a small decrease in cerebral blood flow (35 ± 9 vs. 32 ± 7 ml min-1 100 g-l, mean ± SD, p
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arterioles to acetylcholine in vivo is dependent on formation of NO (Faraci, 1990 (Faraci, , 1991 Rosenblum et aI., 1990) .
In addition to releasing factors that produce re laxation of cerebral blood vessels, endothelium may inhibit responses of vascular muscle to agonists that produce contraction. For example, contraction of cerebral vessels to norepinephrine and serotonin in vitro are augmented by removal of endothelium (Sercombe et aI., 1985; Garland, 1987; Nakagomi et aI., 1988; Connor and Feniuk, 1989; Oudart, 1990 ).
The precise mechanism that accounts for this inhib itory role of endothelium in cerebral vessels is not clear. In peripheral blood vessels, direct contractile effects of norepinephrine and serotonin on vascular muscle are attenuated by simultaneous release of EDRF in vitro (Cocks and Angus, 1983; Luscher and Vanhoutte, 1990) .
It is not known whether EDRF inhibits constric tor responses of cerebral arteries in vivo. The goal of this study was to examine the hypothesis that inhibition of production of EDRF/NO from L-argi nine augments responses of large cerebral arteries to serotonin.
METHODS

Animal preparation
Experiments were performed on 31 New Zealand white rabbits (2. 5-3.5 kg) that were anesthetized with pentobar bital sodium (30 mg kg-I i. v. ). Pentobarbital was supple mented regularly at approximately 10 mg kg -I hr -I. Sup plemental anesthesia was also administered when pres sure to a paw produced a change in blood pressure or heart rate.
The trachea was cannulated, and the animals were ven tilated mechanically with air and supplemental oxygen. A catheter was placed into a femoral artery for measure ment of systemic pressure and to sample arterial blood. A femoral vein was cannulated for infusion of drugs. A dou ble-lumen catheter was inserted in the left atrial append age for injection of microspheres and infusion of seroto nin. Catheters were placed in both brachial arteries for withdrawal of reference blood samples during injection of microspheres. Body temperature was maintained at 37 ± 1°C with a heating pad.
Measurement of microvascular pressure and diameter
Rabbits were placed in a headholder and a craniotomy was performed over the parietal cortex as described in detail (Faraci et aI. , 1987 ). The exposed portion of the brain was suffused with artificial cerebrospinal fluid (CSF) warmed to 37°C. CSF sampled from the cranial window had a pH of 7. 35 ± 0. 02, a PC02 of 39 ± 2 mm Hg, and a P02 of 55 ± 6 mm Hg. After opening the dura mater, a micropipette (tip diameter of 2-3 f.Lm) filled with 0. 8 M NaCI was inserted into a pial arteriole (diameter of 65-160 f.Lm) using a micromanipulator for measurement of microvascular pressure (Servo-Null, model 4A, Instru mentation for Physiology and Medicine, San Diego, CA, U.S.A.). Images were recorded on videotape, and vessel diameters were measured later with an image analyzer.
Measurement of blood flow
Blood flow was measured using radioactive micro spheres (15 f.Lm diameter) labeled with 46SC, 95Nb, 153Gd, 85Sr, 113Sn, and 141Ce (New England Nuclear, Wilming ton, DE, U.S.A.). Before each injection, microspheres were shaken vigorously for several minutes. We injected 0.5-1.3 x 106 spheres into the left atrium in I(}'-20 s, fol lowed by a saline flush. Starting 10 s before the injection of spheres and continuing for 1. 5 min thereafter, refer ence arterial blood samples were withdrawn from both brachial arteries using a withdrawal pump.
At the end of the experiment, the anesthetized rabbit was killed with intravenous potassium chloride. The brain was removed and placed in buffered formalin for 1-2 days before dissection for counting. Radioactivity of tissue samples and reference arterial samples was determined using a 3-in. sodium iodide well-type gamma counter. Iso tope separation was performed using standard tech niques. Blood flow was calculated as (CT x 100 x QR)/ CR, where QR is the reference sample flow rate, and CT and CR are counts in tissue and reference samples, re spectively. Blood flow is expressed in milliliter per minute per 100 g.
We have described the method of measurement and calculation of resistance of large cerebral arteries in detail previously (Faraci et aI., 1987; Heistad et aI., 1987) . Large artery resistance was calculated as (aortic pressure -pial artery pressure)/blood flow to the cerebrum. Small vessel resistance was calculated as pial artery pressure/ blood flow to the cerebrum. Based on previous measure ments (Faraci et al., 1987) , we assumed cerebral venous pressure to be zero. The value that is obtained for the resistance of small vessels includes small pial arterioles, capillaries, and venules. The total cerebral vascular re sistance was calculated as aortic pressure/cerebral blood flow.
Experimental protocol
Three groups of animals were studied. In the first group (n = 12), blood flow and microvascular pressure were Serotonin was infused into the left atrium to avoid me tabolism of the amine in the pulmonary circulation and to simulate the intralumenal source when serotonin is re leased by aggregating platelets. Based on our previous estimation (Williams et aI., 1989) , the dose of serotonin used in this study produces a plasma concentration of serotonin that is in the range of those observed distal to an occlusion of a coronary artery with a thrombus. Thus, the concentration of serotonin that was produced in this study is similar to that which may occur under pathophys iological conditions.
In the second group of rabbits (n = 9), blood flow and microvascular pressure were measured six times: (a) un der control conditions, (b) during infusion of serotonin, (c) during a second control period, (d) during intravenous infusion of L-arginine (L-arginine was administered at 50 mg kg -I min -I during this measurement and was contin ued for the following two measurements), (e) following injection of 3 mg kg-I of L-NNA in the presence of L-arginine, and (f) during infusion of serotonin in the pres ence of L-arginine.
In the third group of rabbits (n = 10), blood flow and microvascular pressure were measured five times: (a) un der control conditions, (b) during hypocapnia (arterial PC02 was reduced by increasing minute ventilation), (c) during a second control period, (d) following injection of L-NNA, and (e) during hypocapnia (15 min following in jection of L-NNA).
Statistics
Statistical analysis was performed using a paired t test to compare various interventions with the preceding con trol. Values obtained after administration of L-NN A were used as a control for effects of serotonin after L-NNA. Bonferroni correction was used for multiple comparisons. All values are expressed as means ± SD. A p value less than 0.05 was considered significant. Cerebral blood flow (ml min -I 100 g-I) 32 ± 8 31 ± 9 32 ± 6 30 ± 6* 28 ± 5** Large artery resistance (mm Hg ml-' min-I 100 g-I)
1
Under control conditions, arterial P02, PC02, and pH averaged 135 ± 17 mm Hg, 36 ± 3 mm Hg, and 7.45 ± 0.07, respectively. These values did not change significantly during the interventions.
All values are means ± SD. * p < 0.05 vs. control; **p < 0.05 vs. L-NNA.
RESULTS
Effects of nitro-L-arginine
The effect of L-NNA on baseline cerebral blood flow and segmental vascular resistance was ob tained in 21 rabbits (n = 11 from group 1; n = 10 from group 3). Under control conditions, intrave nous L-NNA caused a modest, but significant, in crease in aortic pressure (78 ± 6 to 82 ± 6 mm Hg, mean ± SD, p < 0.05) and reduction in cerebral blood flow (35 ± 9 to 32 ± 7 ml min -I 100 g-l, P < 0.05). Resistance of large cerebral arteries in creased from 0.97 ± 0.22 to 1.11 ± 0.28 mm Hg ml-I min -I 100 g-I (15 ± 15% increase, p < 0.05) following administration of L-NNA. In response to L-NNA, small vessel resistance increased from 1.37 ± 0.35 to 1.56 ± 0.46 mm Hg ml-I min-I 100 g-I (14 ± 16% increase, p < 0.05). Total cerebral vas cular resistance increased from 2.34 ± 0.48 to 2.68 ± 0.62 mm Hg ml-I min-I 100 g-' (15 ± 13% increase, p < 0.05). These findings suggest that EDRF affects the cerebral circulation under basal conditions.
Effect of nitro-L-arginine on responses to serotonin and hypocapnia
Infusion of serotonin produced an increase in re sistance of large cerebral arteries without causing any change in cerebral blood flow (Table 1 and Fig.  1 ). Small vessel resistance did not change signifi cantly during infusion of serotonin 0.64 ± 0.46 vs. 1.61 ± 0.52 mmHg ml-' min-1I00 g-'). Following treatment with L-NNA, there was a marked in crease in the response of large cerebral arteries to serotonin. The increase in resistance of large cere bral arteries during infusion of serotonin was in creased more than twofold compared to the control response ( Fig. O. In this group of rabbits, L-NNA increased small vessel resistance from a control value of 1.56 ± 0.37 to 1.81 ± 0.45 mm Hg ml-I min-' 100 g-I (p < 0.05 vs. control). In contrast to effects on large arteries, L-NN A did not augment constrictor responses of small vessels to serotonin. The resistance of small vessels during infusion of J Cereb Blood Flow Metab, Vol. 12, No.3, 1992 serotonin after L-NNA was 1.71 ± 0.62 mm Hg ml-1 min -, 100 g -'. In the presence of L-NN A, serotonin produced a small decrease in cerebral blood flow (Table O. Intravenous infusion of L-arginine had no effect on cerebral blood flow or resistance of large cere bral arteries (Table 2 ). In the presence of L-arginine, L-NNA did not produce an increase in resistance of large cerebral arteries or a decrease in cerebral blood flow, Prior to administration of L-arginine, serotonin tended to increase the resistance of large cerebral arteries (p = 0.06) in this group of rabbits. L-NNA did not augment the response of large cere bral arteries to serotonin in the presence of L-argi nine.
Hypocapnia produced an increase in resistance of large cerebral arteries and a decrease in cerebral blood flow (Fig. 1, Table 3 ). Administration of L-NNA caused a modest increase in resistance of large cerebral arteries and a small decrease in cere bral blood flow (Table 3) . Hypocapnia produced a similar decrease in cerebral blood flow and increase in resistance of large cerebral arteries in the ab sence and presence of L-NNA (Table 3 and 
DISCUSSION
There are several major findings in the present study. First, administration of L-NNA produced a small increase in resistance of cerebral blood ves sels and decrease in cerebral blood flow. L-arginine alone had no effect on cerebral blood flow or resis tance of large cerebral arteries. These findings sug gest that formation of EDRF derived from L-argi nine has a modest influence on the cerebral circu lation under basal conditions. Second, L-NNA produced a marked increase in the constrictor re sponses of large cerebral arteries to serotonin. This finding suggests that basal or serotonin-induced re lease of EDRF inhibits direct constrictor effects of serotonin on large cerebral arteries. Third, effects of L-NNA were specific for serotonin, because con strictor responses of cerebral blood vessels to hy pocapnia were not altered by L-NNA.
Responses to nitro-L-arginine
In the present study, L-NNA was used to inhibit formation of nitric oxide in vivo. Nitro-L-arginine, N1-monomethyl-L-arginine (L-NMMA), and nitro L-arginine methyl ester (L-NAME) have been used for this purpose in a number of studies, both in vitro and in vivo (Moncada et aI., 1991) . These com pounds produce endothelium-dependent contrac tion, endothelium-dependent decreases in cyclic GMP levels in vascular muscle, and selective inhi bition of endothelium-dependent relaxation and in creases in cyclic GMP in smooth muscle (Gold et aI., 1990; Moncada et aI., 1991) . The purified en zyme(s) (nitric oxide synthase or guanylyl cyclase activating-factor synthase) is (are) inhibited by L-NNA and L-NMMA (Bredt and Snyder, 1990; Forstermann et aI., 1991; Schmidt et ai., 1991) .
Recently, these arginine analogues have been used to examine the role of EDRF/NO in the cere bral circulation. L-NMMA and L-NNA produce en dothelium-dependent contraction of isolated cere bral arteries under basal conditions (Katusic and Vanhoutte, 1990; Gonzalez and Estrada, 1991; Lee and Sarwinski, 1991) . Endothelium-dependent re laxation to substance P and acetylcholine is inhib ited by L-NMMA and L-NNA in vitro (Toda and Okamura, 1990; Parsons et ai., 1991) . L-NMMA in hibits dilation of the basilar artery and pial arteri oles in response to acetylcholine, but not to nitro glycerin or sodium nitroprusside, in vivo (Faraci, 1990 (Faraci, , 1991 Mayhan, 1990; Rosenblum et aI., 1990) . Both L-NNA and L-NAME also inhibit dilation of cerebral blood vessels in response to acetylcholine in vivo (Faraci, unpublished observations) .
A recent study suggested that formation of nitric oxide has an important influence on large cerebral arteries under basal conditions (Faraci, 1990) . This conclusion was based on the finding that L-NMMA constricted the basilar artery in vivo. Basal forma tion of EDRF also appears to influence the diameter of pial arterioles, but this effect is significantly less than in large cerebral arteries (Rosenblum et aI., 1990; Faraci, 1991) . Because topical application of L-NMMA con stricts cerebral blood vessels, one might expect that production of EDRF influences cerebral blood flow under basal conditions. In the present study, L-NNA produced a small, but statistically signifi cant, decrease in cerebral blood flow. In a previous study (also in rabbits), the same dose of L-NNA tended to reduce cerebral blood flow (p < 0.1), and the magnitude of change was small (approximately 10%), as in the present study (Faraci and Heistad, 1992) . In a recent study in rats, L-NMMA produced a decrease in regional cerebral blood flow of ap proximately 25-30% (Tanaka et aI., 1991) . The find ing that L-NMMA decreased cerebral blood flow more in rats than L-NNA in rabbits suggests that there may be species differences in the basal influ ence of EDRF or there may be differences in the uptake or metabolism of these arginine analogues (Moncada et aI., 1991) , which make L-NMMA a more effective inhibitor of basal formation of nitric oxide in the cerebral circulation. Katusic (1991) has provided evidence that L-NMMA may be a more effective inhibitor than L-NNA of basal EDRF for mation in cerebral arteries. In addition, a greater influence of EDRF in the rat may relate to the fact that basal levels of cerebral blood flow are greater in the rat than in the rabbit.
In previous studies, L-arginine had little effect on vascular tone or blood flow under normal condi tions (Mondaca et aI., 1991) , suggesting that the availability of L-arginine as a substrate for nitric oxide synthase was not limiting. We (Faraci, 1990 (Faraci, , 1991 Faraci and Heistad, 1991) and others (Busija et aI., 1990; Haberl et aI., 1991) have observed little effect of L-arginine on the diameter of pial arterioles or the basilar artery or cerebral blood flow. In agreement with these previous findings, L-arginine had no significant effect on the resistance of large cerebral arteries or cerebral blood flow.
Responses to serotonin
Effects of serotonin on cerebral blood vessels are complex but serotonin is generally considered a po tent constrictor of large cerebral arteries (Parsons, 1991) . A number of studies have observed increased contraction of peripheral and cerebral arteries in response to serotonin in vitro following removal of the endothelium (Cocks and Angus, 1983; Garland, 1987; Luscher et aI., 1988; Nakagomi et aI., 1988; Connor and Feniuk, 1989; Oudart, 1990) . Hemoglo bin, which binds EDRF, produces endothelium dependent enhancement of contractile responses of the basilar artery to serotonin in vitro (Hongo et aI., 1988) . These findings suggest that endothelium can inhibit contraction of cerebral arteries to serotonin J Cereb Blood Flow Metab, Vol. 12, No.3, 1992 in vitro by release of EDRF. These previous studies in vitro did not examine the nature of the EDRF and can not necessarily predict the magnitude of influ ence of EDRF in vivo, when intact cerebral vessels are exposed to normal levels of blood pressure and blood flow.
Effects of serotonin on the cerebral microcircu lation have not been consistent. Both constriction and dilation of pial arterioles has been observed (Parsons, 1991) . Rosenblum and Nelson (1988) pro vided evidence that suggests that serotonin pro duces modest constriction of pial arterioles that is abolished by injury to the endothelium. Thus, in pial arterioles, endothelium may not inhibit con striction to serotonin by release of EDRF. In the present study, L-NNA did not alter changes in re sistance of small vessels in response to serotonin.
The present study is the first to demonstrate that an inhibitor of NO synthase (L-NNA) augmented responses of large cerebral arteries to serotonin in vivo. A similar effect of L-NNA and L-NMMA on responses to serotonin was observed in the isolated heart in vitro and large coronary arteries in vivo (Cappelli-Bigazzi et aI., 1991; Lamontagne et aI., 1991) . The effect Of L-NNA appears to be somewhat specific for serotonin because constrictor responses of large cerebral arteries to hypocapnia were not altered by the analogue of L-arginine. These find ings suggest that under normal conditions, forma tion of EDRF inhibits constriction of large cerebral arteries to serotonin, but not hypocapnia, in vivo.
Because of the limit in the number of measure ments that can be made using microspheres, only one concentration of serotonin was used in the present study. Because a submaximal dose of sero tonin was used, however, augmented responses of cerebral arteries to serotonin following administra tion of L-NNA could be detected.
This study was performed in anesthetized ani mals. Anesthesia may potentially inhibit responses of cerebral vessels to constrictor stimuli somewhat. However, the presence of anesthesia did not pre vent us from detecting significant vasoconstrictor responses of cerebral arteries to serotonin, L-NNA, and hypocapnia. We can not exclude the possibility that constriction of large arteries in response to these different stimuli may be even greater in con scious animals. Similarly, augmentation of re sponses of large arteries to serotonin by L-NNA may be greater in unanesthetized animals.
Implications
Previous studies have suggested that EDRF de rived from L-arginine influences basal tone and is an important mediator of dilator responses to endothe-lium-dependent agonists in the cerebral circulation (Faraci, 1990 (Faraci, , 1991 Mayhan, 1990; Rosenblum et ai., 1990) . The present study provides the first evi dence in vivo that formation of EDRF modulates responses of large cerebral arteries to a vasocon strictor.
In the cerebral microcirculation, responses to se rotonin have varied. The findings of Rosenblum and Nelson (1988) suggest that serotonin produces en dothelium-dependent constriction in the microcir culation and that endothelial dysfunction may in hibit, not augment, constrictor responses to seroto nin.
The present study suggests that synthesis of EDRF, presumably from endothelium, normally in hibits constrictor responses of large cerebral arter ies to serotonin. The findings in the present study, and in previous studies, suggest that impairment of production of EDRF, by either inhibition of NO synthase or by disease states such as atherosclero sis or chronic hypertension, can augment constric tor responses of large cerebral arteries to serotonin (Heistad et ai., 1987; Mayhan and Faraci, 1990; Rossitch et ai., 1991) . Because aggregation of plate lets can produce high local concentrations of sero tonin, this mechanism may predispose to reduction in cerebral blood flow and thus to cerebral isch emia.
